JPRN-UMIN000023274已完成未知
A double-blind,randomaized,placebo-controlled clinical trial to investigate the effect of the foods containing plant extract(No.SB2805) - A clinical trial to investigate the effect of the foods containing plant extract
SUN BRIGHT CO.,LTD.0 个研究点目标入组 30 人开始时间: 2016年7月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 80years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1)Subject who have serious historical disease,marked impairment,or treatment in the liver,kidney,heart,lung,gastrointestinal tract,blood,endocrine system,or metabolism system 2)Subjects who have previous medical history of drug and/or food allergy 3)Subjects who constantly use oral medicines,functional foods and/or supplements 4)Subjects who are ineligible due to physician's judgment 5)Subjects who participate in other clinical trials
研究者
相似试验
进行中（未招募）
1 期
This is a research study to see whether Lanreotide Autogel will help control the diarrhea and/or flushing caused by carcinoid syndrome.Carcinoid syndromeMedDRA version: 14.1Level: PTClassification code 10007270Term: Carcinoid syndromeSystem Organ Class: 10014698 - Endocrine disordersEUCTR2010-019066-92-CZIpsen Pharma SAS100
进行中（未招募）
不适用
This is a research study to see whether Lanreotide Autogel will help control the diarrhea and/or flushing caused by carcinoid syndrome.Carcinoid syndromeMedDRA version: 14.0Level: PTClassification code 10007270Term: Carcinoid syndromeSystem Organ Class: 10014698 - Endocrine disordersEUCTR2010-019066-92-PLIpsen Pharma SAS100
进行中（未招募）
不适用
A double-blind, randomized placebo-controlled clinical trial investigating theefficacy and safety of Somatuline Depot (lanreotide) Injection in the treatment ofcarcinoid syndrome - NAcarcinoid syndromeMedDRA version: 12.1Level: LLTClassification code 10007270Term: Carcinoid syndromeEUCTR2010-019066-92-LVIpsen Pharma SAS100
进行中（未招募）
1 期
A clinicial trial to investigate te effect of valsartan compared to placebo on acute respiratory failure in hospitalized SARS-CoV-2-infected patientsEUCTR2020-001320-34-NLRadboudumc651
已完成
4 期
A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection DiseaseCOVID-19corona virus infectious disease1004743810024970NL-OMON49095Radboud Universitair Medisch Centrum651